News and Trends 19 Dec 2016 Evotec closes the year partnering with Celgene to treat Alzheimer’s …into solid tumors, inflammatory diseases, and now neurodegenerative conditions, which will include Alzheimer’s, Parkinson’s and amyotrophic lateral sclerosis (ALS) among others. With these ambitious targets, both Celgene and Evotec could… December 19, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 13 Jul 2023 Partnership to progress neurodegenerative disorder treatments …via the Tau Consortium, and the expertise of Weill Cornell Medicine neuroscientist Li Gan to pursue innovative therapies for neurodegenerative disorders. Neurodegenerative disorders include dementias, Parkinson’s disease, Alzheimer’s disease (AD),… July 13, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
News and Trends 17 Oct 2016 Meet the First Biotech to Jump on Autophagy After This Years’ Nobel Prize …for protein quality control, scientists believe that it can be used to prevent and reverse the deposition of misfolded protein aggregates typical of neurodegenerative diseases like Parkinson’s and Alzheimer’s. Worldwide,… October 17, 2016 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 16 May 2018 Swedish Biotech Partners With Novo Nordisk to Advance Stem Cell Therapies for Diabetes …into insulin-producing beta cells that are protected from a patient’s immune system using an encapsulation device. In addition to diabetes, the combined technologies could be used to treat Parkinson’s disease,… May 16, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
News and Trends 8 Mar 2023 The challenges of tackling dementia in women …think that is and what can be done? Dementia and associated neurodegenerative disorders, such as Alzheimer’s and Parkinson’s, are often viewed as normal parts of aging by the general public…. March 8, 2023 - 5 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
Startup Scout 16 Mar 2018 This Belgian Biotech Could Speed Up Diagnoses for Neurodegenerative Diseases …neurodegenerative conditions from Alzheimer’s and Parkinson’s to traumatic brain injury. The anitbodies identify molecules involved in neurodegenerative diseases such as amyloid beta and α-synuclein, which could help diagnose diseases before… March 16, 2018 - 2 minutesmins - By Alexander Burik Share WhatsApp Twitter Linkedin Email
In Depth 18 Jul 2022 Deep phenotyping brings accuracy to precision medicine …patients with Parkinson’s disease. Among other regions in the brain, Parkinson’s disease affects the midbrain, the part responsible for motor activity. Studying the changes in the midbrain is critical to… July 18, 2022 - 8 minutesmins - By Sachin Rawat Share WhatsApp Twitter Linkedin Email
Best in Biotech 14 Nov 2025 10 gene therapy companies you should know about …and U.K. Lead gene therapy candidates: AAV-GAD for Parkinson’s disease and AAV-AQP1 for radiation-induced xerostomia Recent news: Entered into a collaboration with Eli Lilly to develop and commercialize genetic medicines… November 14, 2025 - 15 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 29 May 2020 Spanish Neurology Biotech Launches with €7.6M Series A Accure Therapeutics, a neurology biotech targeting central nervous system (CNS) conditions such as multiple sclerosis and Parkinson’s disease, has launched in Barcelona with a Series A of €7.6M. Alta Life… May 29, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
More News! 17 Jul 2024 Is tau protein the key to defeating Alzheimer’s? Asceneuron thinks so and raises $100 million to prove it …promising potential to prevent the aggregation of proteins that are central to other neurodegenerative diseases, including Parkinson’s disease and amyotrophic lateral sclerosis,” said Henrijette Richter, managing partner at Sofinnova Partners,… July 17, 2024 - 10 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
In Depth 9 Dec 2019 As Big Pharma Abandons Neuroscience, Can Biotech Provide Answers? …all other drugs. Clinical trials in neuroscience, and particularly in neurodegenerative conditions such as Alzheimer’s and Parkinson’s, also tend to be large and complex. This means they usually take longer… December 9, 2019 - 9 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
News and Trends 27 Feb 2020 Scientists Connect Brain Cells to Machines Over the Internet …neural networks and integrate better with real brains. This could lead to implantable AI computing chips that treat complex neurological problems like Parkinson’s disease. One key challenge to developing brain-machine… February 27, 2020 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email